A little over 40 years ago, the first issue of Chain Drug Review appeared. Founded by publisher Susan Schinitsky and editor David Pinto, the publication was positioned, as Pinto said in his first column for Chain Drug Review, as a “biweekly newspaper written and edited specifically for the chain drug industry.” The thrust of the
NEW YORK — At a reception in Manhattan this month, Chain Drug Review honored the recipients of the publication’s Retailer of the Year Awards. In the spotlight before a throng of their retail peers and supplier partners were Alex Gourlay, co-chief operating officer of Walgreens Boots Alliance (WBA), who was named Retailer of the Year; Kevin
SAN ANTONIO — Even the best-run, most effective organizations can benefit from occasionally reconsidering their work in a new light. The National Association of Chain Drug Stores is a case in point. Long viewed as the country’s preeminent retail trade group, NACDS has in recent months broadened and deepened its already formidable commitment to the
WOONSOCKET, R.I. — Kevin Hourican is a relative newcomer to community pharmacy, but that hasn’t prevented him from helping CVS Health live up to its positioning as a pharmacy innovation company. Since being named executive vice president of retail pharmacy and supply chain 18 months ago, Hourican, who was trained in economics and supply chain
DEERFIELD, Ill. — To the casual observer, the dominant story line at Walgreens might appear to be the phased acquisition of 1,932 drug stores and related assets from Rite Aid Corp., and plans for their subsequent assimilation. But, important as the deal is, it shouldn’t be allowed to obscure other compelling developments at Walgreens Boots
Chain Drug Review held a reception in Manhattan earlier this month to honor recipients of the publication’s Retailer of the Year awards. CVS Health president and chief executive officer Larry Merlo named Health Care Executive of the Year, and Walgreens president of pharmacy and retail operations Richard Ashworth was named as Operations Executive of the Year.
NOVI, Mich. — After 26 years as an integral part of the Chain Drug Marketing Association (CDMA) and a lifetime in the chain drug industry, Jim Devine is hanging up his cleats, though he won’t be completely out of the game. Devine stepped down January 1 as CDMA president, but he plans to remain with
ARLINGTON, Va. — In the decade since Steve Anderson became president and chief executive officer of the National Association of Chain Drug Stores, the organization has solidified its position as the preeminent voice for retail pharmacy and established itself as the indispensable network for interaction among those within the sector, and communication between the industry
WOONSOCKET, R.I. — As Larry Merlo sees things, health care delivery in the United States is a tale of two incompatible models, a costly, inefficient one rooted in the past, and another focused on a future of increased patient access, improved outcomes and lower costs. “At the moment, it’s as if we have two health
NEW YORK — The increasing complexity of today’s consumer is making it ever more difficult to tailor stores to shoppers, retailers and suppliers said at the 2016 Chain Drug Review Category Management Roundtable in Manhattan. Conducted in tandem with Market Performance Group (MPG), the roundtable featured 20 executives representing the retailer and supplier viewpoints. Panelists
CHICAGO — Retail pharmacy is no stranger to technology. For many years pharmacy operators and their supply chain partners have relied on computer-driven systems to ensure efficient distribution of products, assist pharmacists in dispensing and adjudicate insurance claims. The digital revolution is now bringing about an exponential change in technology’s impact not only on pharmacy,
NEW YORK — Racher Press Inc., the publisher of Chain Drug Review and Mass Market Retailers, presented its 2015 Retailer of the Year awards last evening in New York City. The annual event drew retailer and supplier executives from across the food, drug and mass channel to a ballroom at the new headquarters of Time
NEW YORK — PharmaSmart International Inc. and Chain Drug Review have launched a groundbreaking partnership designed to help patients lower their blood pressure at the pharmacy point of care. For the next year, the two companies will generate awareness across community pharmacy about hypertension and help jump-start efforts to reduce rates of uncontrolled blood pressure.
NEW YORK — PharmaSmart International Inc. and Chain Drug Review have launched a partnership designed to help pharmacy patients lower their blood pressure. Over the next year, the first-of-its-kind collaboration aims to generate awareness in U.S. and Canadian community pharmacies about hypertension and spur efforts to reduce rates of uncontrolled blood pressure. Under the partnership,